Valion Bio, Inc. (VBIO) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $12.64M | +531.6% |
| 2024 | $2.00M | -41.0% |
| 2023 | $3.40M | -3.5% |
| 2022 | $3.52M | -72.9% |
| 2021 | $12.97M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $12.64M | +531.6% |
| 2024 | $2.00M | -41.0% |
| 2023 | $3.40M | -3.5% |
| 2022 | $3.52M | -72.9% |
| 2021 | $12.97M | — |